- Home
- XOMA vs EDD Comparison
XOMA vs EDD Comparison
Compare XOMA & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- EDD
- Stock Information
- Founded
- XOMA 1981
- EDD 2007
- Country
- XOMA United States
- EDD United States
- Employees
- XOMA N/A
- EDD N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- XOMA Health Care
- EDD Finance
- Exchange
- XOMA Nasdaq
- EDD Nasdaq
- Market Cap
- XOMA 330.2M
- EDD 329.4M
- IPO Year
- XOMA N/A
- EDD N/A
- Fundamental
- Price
- XOMA $32.47
- EDD $5.30
- Analyst Decision
- XOMA Strong Buy
- EDD
- Analyst Count
- XOMA 2
- EDD 0
- Target Price
- XOMA $69.50
- EDD N/A
- AVG Volume (30 Days)
- XOMA 57.0K
- EDD 254.3K
- Earning Date
- XOMA 08-13-2025
- EDD 01-01-0001
- Dividend Yield
- XOMA N/A
- EDD 7.52%
- EPS Growth
- XOMA N/A
- EDD N/A
- EPS
- XOMA N/A
- EDD N/A
- Revenue
- XOMA $44,952,000.00
- EDD N/A
- Revenue This Year
- XOMA $82.30
- EDD N/A
- Revenue Next Year
- XOMA $12.59
- EDD N/A
- P/E Ratio
- XOMA N/A
- EDD N/A
- Revenue Growth
- XOMA 194.98
- EDD N/A
- 52 Week Low
- XOMA $18.35
- EDD $4.22
- 52 Week High
- XOMA $35.23
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- XOMA 61.79
- EDD 56.10
- Support Level
- XOMA $32.60
- EDD $5.24
- Resistance Level
- XOMA $34.60
- EDD $5.42
- Average True Range (ATR)
- XOMA 1.82
- EDD 0.05
- MACD
- XOMA 0.09
- EDD -0.01
- Stochastic Oscillator
- XOMA 66.75
- EDD 40.00
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.